Gene · 406995
Papers1,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer. | J Exp Clin Cancer Res | 2025 | 41422030 | PubTator, text mining | PubMed |
| Exosome therapeutics: A paradigm shift in skin repair through multidimensional immunomodulation and biomaterial-driven delivery. | Biomed Pharmacother | 2025 | 41319522 | PubTator, text mining | PubMed |
| Hypoxia-inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion. | bioRxiv | 2025 | 41279437 | PubTator, text mining | PubMed |
| The multifaceted roles of non-coding RNAs in cell-cell communication in cardiovascular health and disease. | Cell Biosci | 2025 | 41204346 | PubTator, text mining | PubMed |
| Multi-omics analyses integration reveals a novel TRF2-miR-181a-5p-S100A10 regulatory axis in colon cancer. | Cell Mol Biol Lett | 2025 | 41116155 | PubTator, text mining | PubMed |
| Editorial of the Special Issue: Extracellular Vesicles and Exosomes as Therapeutic Agents. | Biomedicines | 2025 | 41007795 | PubTator, text mining | PubMed |
| Expression Analysis of let-7a-5p and miR-21-3p in Extracellular Vesicles Derived from Serum of NSCLC Patients. | Biomedicines | 2025 | 41007624 | PubTator, text mining | PubMed |
| hsa-miR-21-5p can serve as a standard biomarker in clear cell renal cell carcinoma by promoting tumor progression and influencing immune evasion. | Discov Oncol | 2025 | 41003869 | PubTator, text mining | PubMed |
| Integrative assessment of RNA sequencing and in silico analysis to pinpoint mRNAs, lncRNAs, and circRNAs interactions with miRNAs underlying arsenic-induced neurotoxicity. | BMC Genomics | 2025 | 40999364 | PubTator, text mining | PubMed |
| Extracellular vesicles as biomarkers for endometrial cancer - A systematic review. | Transl Oncol | 2025 | 40987065 | PubTator, text mining | PubMed |
| Advance in therapies targeting tumor-associated macrophages in ovarian cancer. | Front Immunol | 2025 | 40963633 | PubTator, text mining | PubMed |
| MicroRNA-320а as a novel biomarker at preclinical stage of necrotizing enterocolitis in term neonates with congenital heart defects. | World J Clin Pediatr | 2025 | 40881071 | PubTator, text mining | PubMed |
| Unveiling exosomes in combating skin aging: insights into resources, mechanisms and challenges. | Stem Cell Res Ther | 2025 | 40877877 | PubTator, text mining | PubMed |
| Therapeutic Potential of Stem Cell-Derived Exosomes in Skin Wound Healing. | Biomimetics (Basel) | 2025 | 40862918 | PubTator, text mining | PubMed |
| Emodin Alleviates Acute Pancreatitis-Associated Acute Lung Injury by Inhibiting Serum Exosomal miRNA-21-3p-Induced M1 Alveolar Macrophage Polarisation. | J Cell Mol Med | 2025 | 40845083 | PubTator, text mining | PubMed |
| Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis. | Sci Rep | 2025 | 40830224 | PubTator, text mining | PubMed |
| MLR Corresponds to the Functional Status of Monocytes in Chronic Lymphocytic Leukemia. | Int J Inflam | 2025 | 40822140 | PubTator, text mining | PubMed |
| [Research progress on the biomarkers of sepsis-induced cardiomyopathy]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2025 | 40820538 | PubTator, text mining | PubMed |
| Exosome mediated delivery of Epigallocatechin 3 gallate as a novel approach to alleviate psoriasis symptoms through cytokine and apoptotic pathway modulation. | Sci Rep | 2025 | 40818978 | PubTator, text mining | PubMed |
| Mechanism of action of decitabine in treating acute lymphoblastic leukemia. | Front Med (Lausanne) | 2025 | 40809438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406995/papers?page=2